Clinical Trial Update: Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 trial update on preventing mother-to-child transmission of HIV-1 without nucleoside reverse transcriptase inhibitors; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Maternal-fetal Infection Transmission | Phase 2 | Status: COMPLETED